Half of US meds launched in 2023 ‘underperformed’

Home / Media Center / Trinity in the News / Half of US meds launched in 2023 ‘underperformed’

The Pharma Letter  |  November 6, 2024

Trinity Life Sciences’ recent white paper on the first year performance of the 2023 launch class was featured in an article published on The Pharma Letter.